Related Experiment Video
Updated: Sep 25, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.4K
A Review of the Impella Devices
Rami Zein1, Chirdeep Patel1, Adrian Mercado-Alamo1
1Interventional Cardiology Department, Ascension St John Hospital and Medical Center Detroit, MI, US.
Interventional Cardiology (London, England)
|April 27, 2022
Summary
Mechanical circulatory support (MCS) devices like Impella heart pumps offer temporary hemodynamic support for cardiogenic shock and high-risk percutaneous coronary interventions. This review details their use, technology, and management strategies.
Area of Science:
- Cardiology
- Medical Devices
- Hemodynamics
Background:
- Mechanical circulatory support (MCS) use for cardiogenic shock and high-risk percutaneous coronary intervention (HRPCI) has increased.
- Lack of consensus exists on best practices for these distinct indications.
Purpose of the Study:
- To provide a comprehensive overview of Impella heart pumps for temporary MCS.
- To detail technical specifications, indications, implantation, and management strategies for Impella devices.
Main Methods:
- Review of technical specifications of Impella heart pumps, Automated Impella Controller, and SmartAssist.
- Discussion of indications, patient selection, implantation techniques, weaning, escalation, closure, anticoagulation, and complications.
Main Results:
- Impella pumps are intravascular microaxial blood pumps for temporary MCS.
- The review covers device specifics, clinical applications, and management protocols.
Conclusions:
- Impella devices represent a significant advancement in temporary MCS.
- Further research and trials are needed to refine best practices for Impella use in cardiogenic shock and HRPCI.
Keywords:
Impellacardiogenic shockhigh-risk percutaneous coronary interventionmechanical circulatory support
